| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Strategic Planning > How to Build Successful Strategic Alliances |
|
E-Folder - How to Build Successful Strategic Alliances
First of all, what is a strategic alliance? A strategic alliance is a partnership, a collaborative According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product agreement and/or a relationship between two or more companies or organizations formed to pursue a ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in et of agreed upon goals while remaining independent companies or organizations. Strategic alliance lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. exist in a variety of shapes and sizes and include a wide range of scopes of cooperation levels. here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe Strategic alliances usually are most effective when the entities involved have complementary streng d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro hs. Here are the ten (10) suggested actions to take to build successful strategic alliances. 1. D ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc velop a focused winning strategy for the alliance that comes from the distinctive competencies and easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi competitive advantages of the partners in he selected target market(s). 2. Develop clearly defined nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically objectives for the alliance to ensure there will not be a goal divergence or conflict between allia and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ce partners. 3. Recruit and select a strategic partner based upon your focused winning strategy, y ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ur goals & objectives and your values system. 4. Develop an effective structure with a clear purpo ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a se to govern and manage the alliance. 5. Develop core competencies in collaboration and look for p dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ople who already have a proven ability to work in a collaborative environment. 6. Prepare to proa cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin tively manage the company cultural challenges that may arise between the alliance partners. 7. Res tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen pect and protect the brand of each partner. 8. Determine and align decision rights to define what t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ecisions are important to the alliance, which partner should make them and how the decisions will b ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust made and monitored. 9. Develop core competencies in change management to most effectively partici y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products pate in a flexible, adaptable strategic alliance. 10. Develop and agree upon an exit strategy for . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de he alliance. It Is important to have agreement in advance on how the alliance will be concluded if elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip and when it may fail and/or when it has fulfilled its mission and achieved its goals and objectives tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Network To Secret Shoppers Job
|